473 related articles for article (PubMed ID: 25448046)
1. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
3. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
4. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
Bond JA; Medinsky MA
Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
[TBL] [Abstract][Full Text] [Related]
5. Cob(I)alamin for trapping butadiene epoxides in metabolism with rat S9 and for determining associated kinetic parameters.
Motwani HV; Fred C; Haglund J; Golding BT; Törnqvist M
Chem Res Toxicol; 2009 Sep; 22(9):1509-16. PubMed ID: 19764821
[TBL] [Abstract][Full Text] [Related]
6. DNA adducts in rats and mice following exposure to [4-14C]-1,2-epoxy-3-butene and to [2,3-14C]-1,3-butadiene.
Boogaard PJ; de Kloe KP; Booth ED; Watson WP
Chem Biol Interact; 2004 Jun; 148(1-2):69-92. PubMed ID: 15223358
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
Csanády GA; Guengerich FP; Bond JA
Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
[TBL] [Abstract][Full Text] [Related]
8. A review of the genetic and related effects of 1,3-butadiene in rodents and humans.
Jackson MA; Stack HF; Rice JM; Waters MD
Mutat Res; 2000 Oct; 463(3):181-213. PubMed ID: 11018742
[TBL] [Abstract][Full Text] [Related]
9. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA
Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
[TBL] [Abstract][Full Text] [Related]
11. 1,3-Butadiene working group report.
Adler ID; Cochrane J; Osterman-Golkar S; Skopek TR; Sorsa M; Vogel E
Mutat Res; 1995 Aug; 330(1-2):101-14. PubMed ID: 7623862
[TBL] [Abstract][Full Text] [Related]
12. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
13. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
[TBL] [Abstract][Full Text] [Related]
14. Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene.
Osterman-Golkar SM; Moss O; James A; Bryant MS; Turner M; Bond JA
Toxicol Appl Pharmacol; 1998 May; 150(1):166-73. PubMed ID: 9630466
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
[TBL] [Abstract][Full Text] [Related]
16. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
Booth ED; Kilgour JD; Robinson SA; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
[TBL] [Abstract][Full Text] [Related]
17. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
18. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
[TBL] [Abstract][Full Text] [Related]
19. A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation.
Johanson G; Filser JG
Arch Toxicol; 1993; 67(3):151-63. PubMed ID: 8494494
[TBL] [Abstract][Full Text] [Related]
20. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides.
Boysen G; Georgieva NI; Upton PB; Walker VE; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):84-92. PubMed ID: 17084829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
